CION Ameerpet
Paediatric Oncology — Treatment & Modalities
Clinical trials for childhood cancer — what parents should know
When your child's oncologist mentions a clinical trial, it can feel both hopeful and frightening at the same time. This page explains what a paediatric cancer trial is, what the safeguards are, how to find one, and what questions to ask — so that whatever you decide, you decide from a clear and steady place.
- Access to newer treatments — trials often offer approaches not yet available as standard care
- Voluntary at every step — you can withdraw your child at any time, for any reason
- Tumour board for every child — our team reviews every case as a group before any recommendation is made
- 45-minute consultation — no rushed decisions; we walk through every option with you
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Understanding paediatric cancer trials
What is a clinical trial — and why is your doctor suggesting one?
A clinical trial for childhood cancer is a research study that tests whether a new treatment, a new combination of existing treatments, or a new sequence of care produces better results than the current standard approach. Trials move through phases: early-phase trials focus on safety and dosing; later-phase trials compare the new approach directly against standard treatment in a larger group of children.
Your child's oncologist does not suggest a trial casually. The recommendation happens when the team believes the trial's approach may be better — more effective, less toxic, or more carefully tailored to your child's specific tumour profile — than what is currently in standard use. Being offered a trial is not a sign that standard options have failed. It is often a sign that the team is thinking carefully about what is best for your child specifically.
Children with cancer have benefited enormously from clinical trials over the past four decades. Most of the treatments that today count as standard of care in paediatric oncology were proven effective inside trials. Every family that chose to participate contributed to knowledge that now helps other children. This does not mean you are obligated to join a trial — the decision is entirely yours — but it is worth understanding this context when you weigh the choice.
The most important thing to remember: participation is voluntary, informed, and revocable at any time. Your child's right to continue receiving the best available standard care is never affected by your decision to join or leave a trial.
Questions to bring to your next appointment
- Why is this specific trial a good match for my child's cancer?
- What is the experimental arm, and what is the control arm?
- If my child is randomised into the control arm, what treatment will they receive?
- What additional visits, tests, or procedures does the trial require?
- Are there any costs to us that would not apply outside the trial?
- What happens if my child experiences a serious side effect?
- Can we withdraw at any point, and will that affect ongoing treatment?
- Is this trial regulated by an ethics committee and CDSCO or equivalent?
The trial enrolment process
How to find and join a paediatric cancer trial — step by step
The process of joining a clinical trial can feel complex, but it follows a logical sequence. Here is what typically happens from the moment your oncologist raises the possibility to the point where your child is enrolled.
1
Your oncologist identifies a relevant trial
Trials are matched to patients based on the cancer type, stage, molecular profile, previous treatments received, and specific eligibility criteria set by the trial protocol. Your oncologist may identify a trial at your own centre, through a network of affiliated centres, or through a national or international research group. Not all children will be eligible for all trials — this is normal and says nothing about how serious or uncommon your child's cancer is. If no suitable trial is open locally, your oncologist may be able to refer you to a centre where one is.
2
The trial is explained to you in detail
A member of the research team — usually a doctor or a trained research nurse — will walk you through the trial's design, the treatment arms, what participation involves in practical terms (additional visits, extra blood draws, questionnaires), and what is known about the experimental treatment's safety from earlier studies. This explanation should be in language you can follow. You are entitled to ask as many questions as you need, and you are encouraged to take the information home before deciding.
3
You are given the informed consent form
The informed consent document is the formal record that you have received a full explanation and understood it. It describes the trial's purpose, the risks and potential benefits, your rights (including the right to withdraw), and who to contact with concerns. Read it carefully. Bring it home. If anything is unclear, ask the research team to explain it again. Children who are old enough — usually around seven years and older, though this varies — are also asked for their assent using an age-appropriate explanation. Both parents and child's assent (if applicable) are documented before enrolment begins.
4
Your child is screened for eligibility
Once you express interest in joining, the research team runs a formal eligibility check against the trial's inclusion and exclusion criteria. This may involve additional blood tests, scans, or a review of pathology results. The screening step exists to protect children — some treatments are only safe for children in a certain health range, or are only appropriate for a specific tumour subtype. If your child does not meet the eligibility criteria, it is not a failure; the oncologist will proceed with the best available standard approach.
5
Your child is enrolled and treatment begins
Once consent is signed and eligibility is confirmed, your child is formally enrolled. In randomised trials, a computer assigns your child to a treatment arm — parents cannot choose which arm. Treatment then begins according to the trial schedule, and the research team monitors your child more closely than is typical for standard care, with regular check-ins, assessments, and reporting of any side effects. You remain free to withdraw at any point. Withdrawal does not affect your right to receive the best available standard treatment outside the trial.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Your child deserves a second opinion — and a full team behind every decision
At CION Cancer Clinics, every child's case is reviewed by our full tumour board before any recommendation is made. We will tell you honestly whether a trial is a good option for your child's specific situation.
What your child may be offered
Types of clinical trials in childhood cancer
Clinical trials are not all the same. They differ in what they test, what phase they are at, and what participation involves. Understanding the differences helps you ask better questions when a trial is proposed.
Phase I
Safety and dosing trials
Phase I trials are the first time a new treatment is tested in children. The main goal is to find the safe dose range and understand how the body handles the treatment. They typically involve small numbers of children who have already received other treatments. Phase I trials offer access to brand-new approaches, but carry more uncertainty about effectiveness because that question comes later.
Phase II
Effectiveness trials
Phase II trials test whether a treatment that proved safe in Phase I actually works against a specific childhood cancer. They involve larger groups of children, are more likely to produce a direct benefit for participants, and are often among the most relevant trials for children who have relapsed after initial treatment or who have a rare cancer where standard options are limited.
Phase III
Comparison trials (standard vs. new)
Phase III trials compare the new approach directly against the current standard of care, usually through randomisation. Every child in a Phase III trial receives an active treatment — either the current standard or the experimental approach. Phase III trials produce the evidence that changes medical guidelines, and children on either arm receive carefully monitored, evidence-based treatment.
Observational
Registry and long-term follow-up studies
Not all studies involve a different treatment. Observational trials collect data about children's outcomes over time — how they respond to standard treatment, what late effects occur, and how quality of life changes. Joining a registry does not change your child's treatment at all but contributes important information about how childhood cancer survivors do in the long term, which helps doctors give better guidance to future families.
Biomarker
Precision medicine and molecular trials
Some trials match children to a treatment based on the molecular or genetic profile of their tumour rather than the tumour's location. These "basket" or "umbrella" trials are growing in paediatric oncology and may be relevant for children whose cancer has an identified genetic alteration. Your child's molecular testing results — if available — are a key factor in eligibility.
Quality of life
Supportive care and late-effects trials
These trials test whether a different support approach — better management of side effects, nutritional support, psychosocial care, or follow-up schedule — improves a child's experience during or after treatment. They do not change the core cancer treatment and carry very low additional risk. They are often a good option when no treatment trial is available but the family wants to contribute to research.
How CION Cancer Clinics supports families considering a trial
At CION, our role is not to push you toward a trial or away from one. Our tumour board reviews your child's case using all available information — including molecular profiling results — and gives you an honest, team-based recommendation about whether a trial is a good option for your child. If we believe it is, we explain why and walk you through the specific trial in detail during a dedicated 45-minute consultation. If we do not believe it is the right path, we tell you that too, and we discuss the best available standard approach.
We can also help coordinate referral to another centre if a suitable trial is not open at our network but is open elsewhere in India or internationally. Decisions for healing, not billing — this applies equally to whether a clinical trial is on the table.
This page provides general information about clinical trials in paediatric oncology. It does not constitute medical advice and is not a substitute for consultation with a qualified oncologist. Clinical trial availability and eligibility are specific to each child's cancer type, treatment history, and current health status. Always discuss clinical trial options directly with your child's treating oncologist.
You are not alone in this
We walk this journey with you — every question, every step
Whether you are weighing a clinical trial or simply want to understand your child's options, our paediatric oncology team will give you honest, team-based guidance — no rush, no unnecessary tests, no billing-driven recommendations.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Your questions about clinical trials for childhood cancer — answered
What is a clinical trial for childhood cancer?
A clinical trial is a carefully designed research study that tests whether a new treatment — or a new way of using an existing treatment — is safe and effective in patients. In paediatric oncology, trials test new approaches against the current standard of care. Your child's doctor does not suggest a trial randomly. They do so when the trial offers access to a treatment that may be more effective, less toxic, or better matched to your child's specific cancer type than current standard options. Participation is always voluntary, and your child can leave a trial at any time without affecting their right to continue receiving other treatment.
Should my child join a clinical trial?
This is one of the most personal decisions a family can face, and there is no single right answer. Consider joining a trial if your child's oncologist recommends it, because the recommendation is based on a careful match between your child's cancer profile and the trial's eligibility criteria. Trials often give access to newer treatments before they are widely available and are conducted with very close monitoring — sometimes closer than standard care. On the other hand, some trials involve additional visits, extra tests, or uncertainty about which treatment arm your child will receive. Ask your oncologist to walk you through the specific benefits and demands of the trial they are proposing before you decide.
Are clinical trials safe for children?
Clinical trials in India and internationally are regulated by ethics committees and drug regulatory authorities whose job is specifically to protect participants. Every trial must have an approved protocol reviewed for safety before any child is enrolled. During the trial, a data safety monitoring board — an independent group of experts — reviews results periodically. If the monitoring board finds that participants on one arm of the trial are doing significantly better or worse, they can pause or stop the trial. The experimental treatment has usually already been tested in adults or in earlier-phase studies, so the team has some safety data before the paediatric trial begins. No trial is without risk, but the safeguards are extensive.
How do I find a clinical trial for my child?
The first step is to ask your child's oncologist whether any trials are open and relevant at your treating centre. Cancer centres affiliated with academic hospitals and ICMR-approved research networks run trials across leukaemia, brain tumours, solid tumours, and rare cancers. You can also search the Clinical Trials Registry India (CTRI, at ctri.nic.in) using your child's cancer type as a search term. Internationally, the US National Cancer Institute's ClinicalTrials.gov lists open trials worldwide, including some that have participating sites in India. If you are interested in a trial not available locally, your oncologist can sometimes arrange referral to a centre where it is open.
What is informed consent for a paediatric clinical trial?
Informed consent is the process by which the research team explains the trial to you in detail — what it involves, what the potential benefits and risks are, what alternatives exist, and what happens if you choose not to participate. For children, parents or guardians give consent on the child's behalf. Children who are old enough to understand are also asked for their "assent" — a separate, age-appropriate agreement — even though the legal decision belongs to the parent. You will be given a written consent form in language you can understand, and you should take time to read it carefully, ask questions, and discuss it with people you trust before signing. Signing informed consent does not lock you in — you can withdraw at any point.
Will my child receive a placebo in a cancer trial?
Placebo-only arms (where a child receives no active treatment) are almost never used in paediatric cancer trials, because withholding all treatment from a child with cancer is considered ethically unacceptable. In most childhood cancer trials, every participant receives at least the current standard of care. The experimental group receives the standard treatment plus the new agent or approach being tested, while the control group receives standard treatment alone. In some trials there is randomisation — a computer randomly assigns which group your child goes into — but this is always between active treatment options, not between treatment and no treatment.
Pediatric Cancer A–Z
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.